These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 37736789)
21. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment. Gao B; Wang Y; Lu S Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232 [TBL] [Abstract][Full Text] [Related]
22. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma. Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
24. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma. Zhang X; Wen Z; Wang Q; Ren L; Zhao S Front Immunol; 2023; 14():1199869. PubMed ID: 37575253 [TBL] [Abstract][Full Text] [Related]
25. Construction of a prognostic risk model based on apoptosis-related genes to assess tumor immune microenvironment and predict prognosis in hepatocellular carcinoma. Wang X; Ji C BMC Gastroenterol; 2022 Aug; 22(1):400. PubMed ID: 36028814 [TBL] [Abstract][Full Text] [Related]
26. An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma. Chen Y; Lin QX; Xu YT; Qian FJ; Lin CJ; Zhao WY; Huang JR; Tian L; Gu DN Front Oncol; 2023; 13():1158605. PubMed ID: 37182175 [TBL] [Abstract][Full Text] [Related]
27. Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma. Xiong X; Song Q; Jing M; Yan W Genet Res (Camb); 2023; 2023():6879022. PubMed ID: 37313428 [TBL] [Abstract][Full Text] [Related]
28. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma. Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899 [TBL] [Abstract][Full Text] [Related]
29. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
30. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes. Liu R; Wang G; Zhang C; Bai D World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023 [TBL] [Abstract][Full Text] [Related]
31. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma. Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A Front Genet; 2022; 13():1039465. PubMed ID: 36338978 [No Abstract] [Full Text] [Related]
32. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis. Zhen Z; Shen Z; Hu Y; Sun P Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885 [TBL] [Abstract][Full Text] [Related]
33. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
34. Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma. Shi Y; Huang G; Jiang F; Zhu J; Xu Q; Fang H; Lan S; Pan Z; Jian H; Li L; Zhang Y Front Immunol; 2022; 13():1070593. PubMed ID: 36544763 [TBL] [Abstract][Full Text] [Related]
35. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes. Yan J; Cao J; Chen Z BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168 [TBL] [Abstract][Full Text] [Related]
36. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma. Zhong Z; Xie F; Yin J; Zhao H; Zhou Y; Guo K; Li R; Wang Q; Tang B Sci Rep; 2023 Sep; 13(1):14723. PubMed ID: 37679418 [TBL] [Abstract][Full Text] [Related]
37. Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity. Zhang D; Liu S; Wu Q; Ma Y; Zhou S; Liu Z; Sun W; Lu Z Front Med (Lausanne); 2023; 10():1232814. PubMed ID: 37502362 [TBL] [Abstract][Full Text] [Related]
38. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
39. Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer. Li C; Weng J; Yang L; Gong H; Liu Z Front Immunol; 2024; 15():1378305. PubMed ID: 38779664 [TBL] [Abstract][Full Text] [Related]
40. Identification of A novel anoikis-related genes-based signature for non-small cell lung cancer. Lei J; Guo G; Liang D; Gong L; Zhang L; Wang X Biochem Biophys Res Commun; 2023 Sep; 673():137-144. PubMed ID: 37385008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]